These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 21699268

  • 1. Long-term outcomes with medications for attention-deficit hyperactivity disorder: current status of knowledge.
    Huang YS, Tsai MH.
    CNS Drugs; 2011 Jul; 25(7):539-54. PubMed ID: 21699268
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.
    Osland ST, Steeves TD, Pringsheim T.
    Cochrane Database Syst Rev; 2018 Jun 26; 6(6):CD007990. PubMed ID: 29944175
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cost effectiveness of guanfacine extended release as an adjunctive therapy to a stimulant compared with stimulant monotherapy for the treatment of attention-deficit hyperactivity disorder in children and adolescents.
    Sikirica V, Haim Erder M, Xie J, Macaulay D, Diener M, Hodgkins P, Wu EQ.
    Pharmacoeconomics; 2012 Aug 01; 30(8):e1-15. PubMed ID: 22788263
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Attention-deficit hyperactivity disorder: recent advances in paediatric pharmacotherapy.
    May DE, Kratochvil CJ.
    Drugs; 2010 Aug 01; 70(1):15-40. PubMed ID: 20030423
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacotherapy of attention-deficit hyperactivity disorder in adolescents.
    Childress AC, Berry SA.
    Drugs; 2012 Feb 12; 72(3):309-25. PubMed ID: 22316347
    [Abstract] [Full Text] [Related]

  • 14. Guanfacine extended release as adjunctive therapy to psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Childress AC.
    Adv Ther; 2012 May 12; 29(5):385-400. PubMed ID: 22610723
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder.
    Biederman J, Spencer T, Wilens T.
    Int J Neuropsychopharmacol; 2004 Mar 12; 7(1):77-97. PubMed ID: 14733627
    [Abstract] [Full Text] [Related]

  • 20. Extended-Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder.
    Price MZ, Price RL.
    CNS Drugs; 2023 Jul 12; 37(7):655-660. PubMed ID: 37430151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.